Pre-Market Trading Boosts Day One (DAWN) Amid High OJEMDA Demand
Fahim Awan
October 31, 2024
Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares are experiencing a significant pre-market rise on the charts, climbing 9.88% to $15.90 after announcing its third-quarter financial